Do you have the same question? Follow this Question
Jul 31, 2025 - 09:41 AM
We’ve provided several answers to questions related to Sotyktu (Deucravacitinib) , see some other helpful Q&A related to this product.
Question: Who authored the package insert for this medication?
Answer: The package insert was authored by Dr. Conor Sheehy, a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. His expertise ensures reliable and comprehensive information for patients and healthcare providers.
Question: Does this medication interact with Basiliximab?
Answer: Yes, there is a potential interaction with Basiliximab. Proper management of drug interactions by healthcare providers ensures that patients receive the maximum benefit from their treatment.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is deucravacitinib. This ingredient is crucial as it is specifically designed to target key pathways involved in immune responses, providing relief for moderate-to-severe plaque psoriasis.
